These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Incidence and predictors of adverse outcomes in patients with rheumatic mitral stenosis following percutaneous balloon mitral valvuloplasty: a study from a tertiary center in Thailand. Songduang K, Kaolawanich Y, Karaketklang K, Ratanasit N. BMC Cardiovasc Disord; 2024 Jul 29; 24(1):391. PubMed ID: 39069638 [Abstract] [Full Text] [Related]
10. The role of three dimensional transesophageal echocardiography novel-score in the success of redo percutaneous balloon mitral valvuloplasty. Sancar KM, Guler GB, Tanboga HI, Demir AR, Sahin AA, Tasbulak O, Karakurt ST, Aktemur T, Avci Y, Bulut U, Tekin M, Guler E, Kalkan AK, Erturk M. Int J Cardiovasc Imaging; 2022 Mar 29; 38(3):621-629. PubMed ID: 34689249 [Abstract] [Full Text] [Related]
11. Mid-term (up to 12 years) clinical and echocardiographic outcomes of percutaneous transvenous mitral commissurotomy in patients with rheumatic mitral stenosis. Dadjo Y, Moshkani Farahani M, Nowshad R, Sadeghi Ghahrodi M, Moaref A, Kojuri J. BMC Cardiovasc Disord; 2021 Jul 28; 21(1):355. PubMed ID: 34320949 [Abstract] [Full Text] [Related]
12. Application of percutaneous balloon mitral valvuloplasty in patients of rheumatic heart disease mitral stenosis combined with tricuspid regurgitation. Chen ZQ, Hong L, Wang H, Lu LX, Yin QL, Lai HL, Li HT, Wang X. Chin Med J (Engl); 2015 Jun 05; 128(11):1479-82. PubMed ID: 26021504 [Abstract] [Full Text] [Related]
13. Role of three dimensional transesophageal echocardiography in predicting mitral regurgitation after percutaneous balloon mitral valvuloplasty. Alkhouly AA, Al-Amin AM, Mukarrab MI. Indian Heart J; 2018 Jun 05; 70(6):836-842. PubMed ID: 30580853 [Abstract] [Full Text] [Related]
14. Management of mitral stenosis using 2D and 3D echo-Doppler imaging. Wunderlich NC, Beigel R, Siegel RJ. JACC Cardiovasc Imaging; 2013 Nov 05; 6(11):1191-205. PubMed ID: 24229772 [Abstract] [Full Text] [Related]
15. Should we wait until severe pulmonary hypertension develops? Efficacy of percutaneous mitral balloon valvuloplasty in patients with severe pulmonary hypertension: A subgroup analysis of our experience. Ozkan H, Bozat T, Tiryakioglu SK, Ari H. Cardiol J; 2016 Nov 05; 23(2):184-8. PubMed ID: 26876064 [Abstract] [Full Text] [Related]
16. Percutaneous balloon mitral valvuloplasty for mitral stenosis with and without associated aortic regurgitation. Chen CR, Cheng TO, Chen JY, Zhou YL, Mei J, Ma TZ. Am Heart J; 1993 Jan 05; 125(1):128-37. PubMed ID: 8417508 [Abstract] [Full Text] [Related]
17. Redo Scoring for Prediction of Success of Redo-Percutaneous Balloon Mitral Valvuloplasty in Patients with Mitral Restenosis. Mahfouz RA, Elawady W, Goda M, Moustafa T. J Heart Valve Dis; 2017 Sep 05; 26(5):537-546. PubMed ID: 29762922 [Abstract] [Full Text] [Related]
18. Pulmonary vascular resistance and proper timing of percutaneous balloon mitral valvotomy. Elmaghawry LM, El-Dosouky II, Kandil NT, Sayyid-Ahmad AMS. Int J Cardiovasc Imaging; 2018 Apr 05; 34(4):523-529. PubMed ID: 29086226 [Abstract] [Full Text] [Related]
19. NT-ProBNP as a Potential Marker of Left Atrial Dysfunction in Rheumatic Mitral Stenosis: Correlation with Left Atrial Function after PBMV. Khare R, Dwivedi S. J Heart Valve Dis; 2016 Sep 05; 25(5):613-618. PubMed ID: 28238244 [Abstract] [Full Text] [Related]
20. Influence of commissural calcification on the immediate outcomes of percutaneous balloon mitral valvuloplasty. Wei T, Zeng C, Chen F, Wang C, Chen L, Chen Q, Lan W, Wang L. Acta Cardiol; 2003 Oct 05; 58(5):411-5. PubMed ID: 14609306 [Abstract] [Full Text] [Related] Page: [Next] [New Search]